Form D/A — PHYXTRADE LTD
0002076625-25-000005 · filed Jul 11, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Banking and Financial Services filings
Offering
- Industry
- Other Banking and Financial Services
- Exemptions
- Rule 504(b)(1), other, Rule 504(b)(1)(i), Rule 504(b)(1)(ii), Rule 504(b)(1)(iii), Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(10), Investment Company Act Section 3(c)(11), Investment Company Act Section 3(c)(12), Investment Company Act Section 3(c)(13), Investment Company Act Section 3(c)(14), Investment Company Act Section 3(c)(2), Investment Company Act Section 3(c)(3), Investment Company Act Section 3(c)(4), Investment Company Act Section 3(c)(5), Investment Company Act Section 3(c)(6), Investment Company Act Section 3(c)(7), Investment Company Act Section 3(c)(9), Securities Act Section 4(a)(5)
- Reported offering amount
- —
- Reported amount sold
- $100,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- PHYXTRADE LTD
- CIK
- 2076625
- Entity
- Corporation
- Jurisdiction
- UNITED KINGDOM
- Year incorporated
- 2025
- Address
- 32 LONDON BRIDGE ST
LONDON, United Kingdom SE1 9SG - Phone
- 00447548588045
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Apiz Bin Mohamad · DirectorLondon, United Kingdom Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗